APO-Perindopril Arginine/Amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APX-PERINDOPRIL ARGININE/ AMLODIPINE 10/10 perindopril arginine 10 mg/ amlodipine 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apx-perindopril arginine/ amlodipine 10/10 perindopril arginine 10 mg/ amlodipine 10 mg uncoated tablet bottle

servier laboratories (aust) pty ltd - amlodipine besilate, quantity: 13.87 mg; perindopril arginine, quantity: 10 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate; magnesium stearate - apx-perindopril arginine/ amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APX-PERINDOPRIL ARGININE/ AMLODIPINE 10/5 perindopril arginine 10 mg/ amlodipine 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apx-perindopril arginine/ amlodipine 10/5 perindopril arginine 10 mg/ amlodipine 5 mg uncoated tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 6.935 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - apx-perindopril arginine/ amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APX-PERINDOPRIL ARGININE/ AMLODIPINE 5/10 perindopril arginine 5 mg/ amlodipine 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apx-perindopril arginine/ amlodipine 5/10 perindopril arginine 5 mg/ amlodipine 10 mg uncoated tablet bottle

servier laboratories (aust) pty ltd - amlodipine besilate, quantity: 13.87 mg; perindopril arginine, quantity: 5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; lactose monohydrate - apx-perindopril arginine/ amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APX-PERINDOPRIL ARGININE/ AMLODIPINE 5/5 perindopril arginine 5 mg/ amlodipine 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apx-perindopril arginine/ amlodipine 5/5 perindopril arginine 5 mg/ amlodipine 5 mg uncoated tablet bottle

servier laboratories (aust) pty ltd - amlodipine besilate, quantity: 6.935 mg; perindopril arginine, quantity: 5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - apx-perindopril arginine/ amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

AMLODIPINE SANDOZ amlodipine besilate 10mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine sandoz amlodipine besilate 10mg tablet bottle

sandoz pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, uncoated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; sodium starch glycollate; magnesium stearate - hypertension: first line treatment of hypertension. it can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine besylate, which has been used in combination with a thiazide diuretic, beta-adrenoreceptor blocking agent, or an angiotensin converting enzyme inhibitor. angina: first line treatment of chronic stable angina. amlodipine besylate may be used alone, as monotherapy, or in combination with other antianginal drugs.

AMLODIPINE SANDOZ amlodipine besilate 5mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine sandoz amlodipine besilate 5mg tablet bottle

sandoz pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; calcium hydrogen phosphate; sodium starch glycollate; microcrystalline cellulose - hypertension: first line treatment of hypertension. it can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine besylate, which has been used in combination with a thiazide diuretic, beta-adrenoreceptor blocking agent, or an angiotensin converting enzyme inhibitor. angina: first line treatment of chronic stable angina. amlodipine besylate may be used alone, as monotherapy, or in combination with other antianginal drugs.

AMLODIPINE SANDOZ amlodipine besilate 2.5mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine sandoz amlodipine besilate 2.5mg tablet bottle

sandoz pty ltd - amlodipine besilate, quantity: 3.47 mg (equivalent: amlodipine, qty 2.5 mg) - tablet, uncoated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; sodium starch glycollate; magnesium stearate - hypertension: first line treatment of hypertension. it can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine besylate, which has been used in combination with a thiazide diuretic, beta-adrenoreceptor blocking agent, or an angiotensin converting enzyme inhibitor. angina: first line treatment of chronic stable angina. amlodipine besylate may be used alone, as monotherapy, or in combination with other antianginal drugs.

AMLODIPINE SANDOZ amlodipine besilate 2.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine sandoz amlodipine besilate 2.5mg tablet blister pack

sandoz pty ltd - amlodipine besilate, quantity: 3.47 mg (equivalent: amlodipine, qty 2.5 mg) - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; calcium hydrogen phosphate; magnesium stearate - hypertension: first line treatment of hypertension. it can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine besylate, which has been used in combination with a thiazide diuretic, beta-adrenoreceptor blocking agent, or an angiotensin converting enzyme inhibitor. angina: first line treatment of chronic stable angina. amlodipine besylate may be used alone, as monotherapy, or in combination with other antianginal drugs.

APO-Perindopril Arginine/Amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.